Jin‐Seok Ahn

757 total citations
20 papers, 421 citations indexed

About

Jin‐Seok Ahn is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jin‐Seok Ahn has authored 20 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jin‐Seok Ahn's work include Breast Cancer Treatment Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (4 papers). Jin‐Seok Ahn is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (4 papers). Jin‐Seok Ahn collaborates with scholars based in South Korea, United States and Russia. Jin‐Seok Ahn's co-authors include Jeeyun Lee, Seok Jin Nam, Myung‐Ju Ahn, Young‐Hyuck Im, Boo‐Kyung Han, Keunchil Park, Jung‐Hyun Yang, Jason A. Zell, Yeon Hyeon Choe and Yoon‐La Choi and has published in prestigious journals such as Cancer, European Journal of Cancer and Journal of Pain and Symptom Management.

In The Last Decade

Jin‐Seok Ahn

20 papers receiving 417 citations

Peers

Countries citing papers authored by Jin‐Seok Ahn

Since Specialization

Citations

This map shows the geographic impact of Jin‐Seok Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin‐Seok Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin‐Seok Ahn more than expected).

Fields of papers citing papers by Jin‐Seok Ahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin‐Seok Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin‐Seok Ahn. The network helps show where Jin‐Seok Ahn may publish in the future.

Co-authorship network of co-authors of Jin‐Seok Ahn

This figure shows the co-authorship network connecting the top 25 collaborators of Jin‐Seok Ahn. A scholar is included among the top collaborators of Jin‐Seok Ahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin‐Seok Ahn. Jin‐Seok Ahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study 2023 ·Cancers ·(unknown), (unknown), Joon Young Choi, (unknown), (unknown), (unknown), (unknown), Jin‐Seok Ahn, Byung Joo Chae, Jonghan Yu, Jeong Eon Lee, Seok Won Kim, Seok Jin Nam, Jai Min Ryu	6
2	Osimertinib Combined with Systemic Chemotherapy for EGFR Mutant, T790M-Negative, Non–Small Cell Lung Cancer Patients Who Develop Leptomeningeal Metastases with Extracranial Progression to Prior EGFR TKI 2022 ·Cancer Research and Treatment ·Hye Ryeon Kim, Hyunji Jo, Hong-Sik Kim, Joo-Hyun Hong, Sehhoon Park, Hyun Ae Jung, Se‐Hoon Lee, Jin‐Seok Ahn, Myung‐Ju Ahn	4
3	Reliability and Validity of the Korean Language Version of the U.S. National Cancer Institute's Patient-Reported Outcomes Common Terminology Criteria for Adverse Events 2020 ·Journal of Pain and Symptom Management ·(unknown), Sung Hoon Sim, Danbee Kang, (unknown), Youngha Kim, Jin‐Seok Ahn, Dongryul Oh, Eun Sook Lee, (unknown), Juhee Cho, Sandra A. Mitchell	2
4	Linguistic Validation of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in Korean 2019 ·Journal of Global Oncology ·Juhee Cho, (unknown), Youngha Kim, Dongryul Oh, Seok Jin Kim, Jin‐Seok Ahn, Gee Young Suh, Seok Jin Nam, Sandra A. Mitchell	17
5	Clinical activity of fulvestrant in metastatic breast cancer previously treated with endocrine therapy and/or chemotherapy 2018 ·The Korean Journal of Internal Medicine ·Mi Hwa Heo, Hee Kyung Kim, Hansang Lee, Ji‐Yeon Kim, Jin‐Seok Ahn, Young‐Hyuck Im, Yeon Hee Park	3
6	Long‐term effects of crizotinib in ALK‐positive tumors (excluding NSCLC): A phase 1b open‐label study 2018 ·American Journal of Hematology ·Carlo Gambacorti‐Passerini, Sergey Orlov, Li Zhang, Fadi Braiteh, Huiqiang Huang, Taito Esaki, Keizo Horibe, Jin‐Seok Ahn, J. Thaddeus Beck, W. Jeffrey Edenfield, Yuankai Shi, Matthew H. Taylor, Kenji Tamura, Brian A. Van Tine, Shang‐Ju Wu, Jolanda Paolini, Paulina Selaru, Tae Min Kim	74
7	Breast Cancer Epidemiology of the Working-Age Female Population Reveals Significant Implications for the South Korean Economy 2018 ·Journal of Breast Cancer ·Jeong Hyun Park, Se Kyung Lee, Joon Jeong, Seok Won Kim, Seok Jin Nam, Ji‐Yeon Kim, Jin‐Seok Ahn, Won Park, Jonghan Yu, Winnie Yeo	10
8	Cancer Pain Management Education Rectifies Patients’ Misconceptions of Cancer Pain, Reduces Pain, and Improves Quality of Life 2018 ·Pain Medicine ·Su‐Jin Koh, Bhumsuk Keam, Min Kyung Hyun, (unknown), Keon Uk Park, Sung Yong Oh, Jin‐Seok Ahn, Ja Youn Lee, JinShil Kim	26
9	Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial 2017 ·Chinese Journal of Cancer ·Kyung-Hee Lee, Tae Won Kim, (unknown), Jin-Soo Kim, Jin‐Seok Ahn, Sun‐Young Kim, Hwan‐Jung Yun, (unknown), (unknown), Min Kyoung Kim, Yong Sang Hong, Jeong Eun Kim, Gyeong‐Won Lee	10
10	HannaH phase III randomised study: Association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated with neoadjuvant–adjuvant trastuzumab after 2 years of treatment-free follow-up 2016 ·European Journal of Cancer ·Christian Jackisch, Roberto Hegg, Daniil Stroyakovskiy, Jin‐Seok Ahn, Bohuslav Melichar, Shin‐Cheh Chen, Sung‐Bae Kim, Mikhail Lichinitser, Elżbieta Starosławska, Georg Kunz, S. Falcon, Shou‐Tung Chen, (unknown), Dominik Heinzmann, Mona Shing, Xavier Pivot	58
11	Outcomes of Gamma Knife Radiosurgery in Combination with Crizotinib for Patients with Brain Metastasis from Non–Small Cell Lung Cancer 2016 ·World Neurosurgery ·Jung Won Choi, Doo‐Sik Kong, Ho Jun Seol, Do‐Hyun Nam, Kwai Han Yoo, Jong‐Mu Sun, Jin‐Seok Ahn, Myung‐Ju Ahn, Keunchil Park, Jung-Il Lee	2
12	Crash Optimization of an Automobile Frontal Structure Using Equivalent Static Loads 2015 ·Transactions of Korean Society of Automotive Engineers ·(unknown), Jin‐Seok Ahn, Gyung-Jin Park	9
13	Survey of the Application of the Korean Clinical Practice Recommendations on Breast Cancer Treatment: The Utility of the Korean Breast Cancer Society Guidelines 2012 ·Journal of Breast Cancer ·Geumhee Gwak, Hae Kyung Lee, (unknown), (unknown), Yong Lai Park, Jong Won Lee, (unknown), (unknown), (unknown), Je Ryong Kim, Jin‐Seok Ahn, (unknown), (unknown), Woo Chan Park, Sung Yong Kim, Sehwan Han, Eun Sook Lee, (unknown)	5
14	Korean Ethnicity as Compared with White Ethnicity Is an Independent Favorable Prognostic Factor for Overall Survival in Non-small Cell Lung Cancer before and after the Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Era 2010 ·Journal of Thoracic Oncology ·Myung‐Ju Ahn, Jeeyun Lee, Yun‐Hee Park, Jin‐Seok Ahn, Argyrios Ziogas, Jason A. Zell, Keunchil Park, Sai‐Hong Ignatius Ou	47
15	The dosing frequency of sustained-release opioids and the prevalence of end-of-dose failure in cancer pain control: a Korean multicenter study 2010 ·Supportive Care in Cancer ·(unknown), (unknown), Jin‐Seok Ahn, Baek‐Yeol Ryoo, Dongbok Shin, Chang‐Yeol Yim, Siyoung Kim	8
16	Clinical impact of phosphorylated signal transducer and activator of transcription 3, epidermal growth factor receptor, p53, and vascular endothelial growth factor receptor 1 expression in resected adenocarcinoma of lung by using tissue microarray 2010 ·Cancer ·Hyeong Su Kim, Winnie Yeo, Jeeyun Lee, Jin‐Seok Ahn, Jinkook Kim, Young Mog Shim, Jung Han Kim, Keunchil Park, Joungho Han, Myung‐Ju Ahn	29
17	The Fluorescence Immunoassay of lung Cancer Serum Diomarkers using Quantum dots 2009 ·Journal of Biomedical Engineering Research ·(unknown), Jin‐Seok Ahn, (unknown), (unknown), (unknown), Won-Seog Kim, (unknown)	1
18	The role of PET CT to evaluate the response to neoadjuvant chemotherapy in advanced breast cancer: Comparison with ultrasonography and magnetic resonance imaging 2009 ·Journal of Surgical Oncology ·Jae Hyuck Choi, Hye In Lim, Se Kyung Lee, Wan Wook Kim, Sang Min Kim, (unknown), Eun Young Ko, Boo‐Kyung Han, Yeon Hee Park, Jin‐Seok Ahn, Young‐Hyuck Im, Jeong Eon Lee, Jung‐Hyun Yang, Seok Jin Nam	40
19	Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: Relation to response patterns on MRI 2007 ·Acta Oncologica ·Hyun Jung Kim, Young‐Hyuck Im, Boo‐Kyung Han, Nami Choi, Jeeyun Lee, Yoon‐La Choi, Jin‐Seok Ahn, Seok Jin Nam, Young Suk Park, Yeon Hyeon Choe, Young Hyeh Ko, Jung‐Hyun Yang	68
20	Causes and Clinical Features of Vitamine $B_{12}$ Deficiency Megaloblastic Anemia 2004 ·Blood Research ·(unknown), (unknown), Jeong Han Kim, Jooyoung Jeong, Hyo‐Jeong Kim, (unknown), (unknown), Jin‐Seok Ahn, Donghoon Shin, (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact